BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/15/2019 10:17:12 AM | Browse: 182 | Download: 147
Publication Name World Journal of Diabetes
Manuscript ID 47997
Country/Territory United States
2019-04-01 01:57
Peer-Review Started
2019-04-04 07:26
To Make the First Decision
2019-05-09 00:30
Return for Revision
2019-05-09 02:16
2019-05-13 00:53
Second Decision
2019-05-13 11:05
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2019-05-14 01:27
Articles in Press
2019-05-14 01:27
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2019-05-14 09:49
Publish the Manuscript Online
2019-05-15 10:17
ISSN 1948-9358 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Endocrinology and Metabolism
Manuscript Type Minireviews
Article Title Novel pharmacological therapy in type 2 diabetes mellitus with established cardiovascular disease: Current evidence
Manuscript Source Invited Manuscript
All Author List Leonardo Pozo, Fatimah Bello, Andres Suarez, Francisco E Ochoa-Martinez, Yamely Mendez, Chelsea H Chang and Salim Surani
Author(s) ORCID Number
Leonardo Pozo http://orcid.org/0000-0002-6352-1423
Fatimah Bello http://orcid.org/0000-0002-5841-6987
Andres Suarez http://orcid.org/0000-0002-2884-1755
Francisco E Ochoa-Martinez http://orcid.org/0000-0001-5987-857X
Yamely Mendez http://orcid.org/0000-0002-0863-6236
Chelsea H Chang http://orcid.org/0000-0001-8309-5911
Salim Surani http://orcid.org/0000-0001-7105-4266
Funding Agency and Grant Number
Corresponding author Salim Surani, BSc, FACC, FACP, FCCP, MD, Professor, Medical Critical Care Services, Christus Spohn Hospitals-Corpus Christi, 701 Ayers street, Corpus Christi, TX78404, United States. srsurani@hotmail.com
Keywords Type 2 diabetes mellitus; Glucagon-like-peptide 1 agonists; Sodium-glucose cotransporter-2 inhibitor; Cardiovascular disease; Major adverse cardiovascular event
Core Tip Cardiovascular diseases are of significant concern in patients with type 2 diabetes mellitus. Novel therapies offer a new opportunity for cardiovascular risk reduction and add complexity in terms of selecting antihyperglycemic treatment. These pharmacological therapies, however, also have additional considerations.
Publish Date 2019-05-15 10:17
Citation Pozo L, Bello F, Suarez A, Ochoa-Martinez FE, Mendez Y, Chang CH, Surani S. Novel pharmacological therapy in type 2 diabetes mellitus with established cardiovascular disease: Current evidence. World J Diabetes 2019; 10(5): 291-303
Url https://www.wjgnet.com/1948-9358/full/v10/i5/291.htm
DOI https://dx.doi.org/10.4239/wjd.v10.i5.291
Full Article (PDF) WJD-10-291.pdf
Full Article (Word) WJD-10-291.docx
Manuscript File 47997-Review.docx
Answering Reviewers 47997-Answering reviewers.pdf
Audio Core Tip 47997-Audio core tip.mp3
Conflict-of-Interest Disclosure Form 47997-Conflict-of-interest statement.pdf
Copyright License Agreement 47997-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate 47997-Language certificate.pdf
Peer-review Report 47997-Peer-review(s).pdf
Scientific Misconduct Check 47997-Scientific misconduct check.pdf
Scientific Editor Work List 47997-Scientific editor work list.pdf